Compare with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES LUPIN ALKEM LABORATORIES/
LUPIN
 
P/E (TTM) x - 46.0 - View Chart
P/BV x 6.6 2.4 280.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   LUPIN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
LUPIN
Mar-19
ALKEM LABORATORIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,589986 161.2%   
Low Rs1,232720 171.0%   
Sales per share (Unadj.) Rs417.5369.5 113.0%  
Earnings per share (Unadj.) Rs56.313.4 420.0%  
Cash flow per share (Unadj.) Rs64.737.4 173.1%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9303.7 96.5%  
Shares outstanding (eoy) m119.57452.49 26.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.42.3 146.3%   
Avg P/E ratio x25.163.6 39.4%  
P/CF ratio (eoy) x21.822.8 95.5%  
Price / Book Value ratio x4.82.8 171.4%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,653386,064 43.7%   
No. of employees `000NA17.7 0.0%   
Total wages/salary Rs m9,17131,513 29.1%   
Avg. sales/employee Rs ThNM9,453.8-  
Avg. wages/employee Rs ThNM1,782.0-  
Avg. net profit/employee Rs ThNM343.0-  
INCOME DATA
Net Sales Rs m49,915167,182 29.9%  
Other income Rs m1,6453,640 45.2%   
Total revenues Rs m51,561170,822 30.2%   
Gross profit Rs m8,48228,822 29.4%  
Depreciation Rs m1,00610,850 9.3%   
Interest Rs m6713,078 21.8%   
Profit before tax Rs m8,45118,534 45.6%   
Minority Interest Rs m-114-89 127.4%   
Prior Period Items Rs m038 0.0%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m1,6069,017 17.8%   
Profit after tax Rs m6,7316,066 111.0%  
Gross profit margin %17.017.2 98.6%  
Effective tax rate %19.048.7 39.1%   
Net profit margin %13.53.6 371.7%  
BALANCE SHEET DATA
Current assets Rs m27,062138,536 19.5%   
Current liabilities Rs m15,32461,299 25.0%   
Net working cap to sales %23.546.2 50.9%  
Current ratio x1.82.3 78.1%  
Inventory Days Days6784 79.4%  
Debtors Days Days41112 36.7%  
Net fixed assets Rs m12,610127,516 9.9%   
Share capital Rs m239905 26.4%   
"Free" reserves Rs m34,490136,517 25.3%   
Net worth Rs m35,027137,422 25.5%   
Long term debt Rs m1,21266,417 1.8%   
Total assets Rs m54,387279,494 19.5%  
Interest coverage x13.67.0 193.7%   
Debt to equity ratio x00.5 7.2%  
Sales to assets ratio x0.90.6 153.4%   
Return on assets %13.63.3 416.0%  
Return on equity %19.24.4 435.4%  
Return on capital %24.98.9 279.0%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56359,414 11.0%   
Fx outflow Rs m3,01222,282 13.5%   
Net fx Rs m3,55237,132 9.6%   
CASH FLOW
From Operations Rs m7,25916,660 43.6%  
From Investments Rs m1,864-32,825 -5.7%  
From Financial Activity Rs m-9,2737,441 -124.6%  
Net Cashflow Rs m-150-8,724 1.7%  

Share Holding

Indian Promoters % 66.9 46.6 143.6%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 33.1 11.3 292.9%  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.1 -  
Shareholders   68,381 98,259 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT  NOVARTIS  PLETHICO PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views on News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 14, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS